Article
HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
Oncology reports - 1 May 2015
Ji Meiying, Lee Eun Jeoung, Kim Ki Bae, Kim Yangmi, Sung Rohyun, Lee Sang-Jeon, Kim Don Soo, Park Seon Mee
Abstract excerpt
The effects of histone deacetylase (HDAC) inhibitors on epithelial-mesenchymal transition (EMT) differ in various types of cancers. We investigated the EMT phenotype in four colon cancer cell lines when challenged with HDAC inhibitors trichostatin A (TSA) and valproic acid (VPA) with or without transforming growth factor-β1 (TGF-β1) treatment. Four colon cancer cell lines with different phenotypes in regards to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
